Form D · Other Technology

Ativa Medical Corp

St. Paul, MN · CIK 0001475620

Offering snapshot reported Jul 7, 2017 · SEC filing

Reported sold
$9.5M
Offering amount: $20M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 23, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 7, 2017Initial$9,500,000No comparison2SEC filing
Aug 28, 2015Initial$23,172,820No comparison65SEC filing
Jun 5, 2013Initial$165,000No comparison3SEC filing
Jul 16, 2012Amendment$3,368,014$3,093,014vs Jan 24, 201240SEC filing
Jan 24, 2012Initial$275,000No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-290223

Source: Form D, filed Jul 7, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark Bagnall Director
David W Deetz Director, Executive
Robert S. Galen Director, Executive
Dennis J. Mc Fadden Executive
James M Mc Nally Director, Executive
Jon Meltzer Director
Travis L Murphy Executive
Tiffany P. Olson Director
Franklyn G. Prendergast Director
Barbara E Roth Executive
Randall K. Seeliger Executive
James B Stake Director
Dale A Wahlstrom Director
Jiang Zhang Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
1000 Westgate Drive Suite 100
St. Paul, MN, 55114